IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.
about
Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensinsPeptides and Peptidomimetics for Antimicrobial Drug DesignOligomerization of the antimicrobial peptide Protegrin-5 in a membrane-mimicking environment. Structural studies by high-resolution NMR spectroscopy.Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptidesComparison of interactions between beta-hairpin decapeptides and SDS/DPC micelles from experimental and simulation data.Oral and intestinal mucositis - causes and possible treatments.Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microfloraAntimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coliPeptide-based Antifungal Therapies against Emerging Infections.High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residuesIseganan HCl: a novel antimicrobial agent.Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications.Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantiumOral mucositis: time for more studies.Effects of antimicrobial peptide L-K6, a temporin-1CEb analog on oral pathogen growth, Streptococcus mutans biofilm formation, and anti-inflammatory activity.Cationic antimicrobial peptides - an update.Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activityThe roles of antimicrobial peptides in innate host defense.Computational studies of peptide-induced membrane pore formation.In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluidsPhysicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.Antimicrobial Peptides in Biomedical Device Manufacturing.Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats.Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs.Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide.Antimicrobial peptides from plants: stabilization of the γ core of a tomato defensin by intramolecular disulfide bond.Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus.Rings of destructionAntibacterial Activity of Synthetic Peptides Against Plant Pathogenic Pectobacterium Species
P2860
Q24641895-DDB65A45-30D6-4250-A007-53705F819479Q26799959-DD271B64-5F2F-4678-B547-34602F5F3219Q30152731-891F24FB-D4DA-4A11-B902-F9DE478CA41AQ30992994-E166A172-F542-476B-B5E8-DE4524BAECC3Q31119012-4B3E5D19-33A2-412F-AD25-A16AA764BC55Q33195001-7CAA1ADC-742E-4EA2-B9B5-83ED7F7BB727Q33260522-4B98629E-0E72-4557-B15A-E0C3F7BB0AA4Q33674830-6D9AF12F-022F-4457-AB15-CC91C7D0E41EQ33862289-D341ED43-CBC4-4385-8905-58415B3CB252Q33983134-538FFA50-8AE7-4F90-9297-D7A85EF97833Q34455145-AF179FE2-50E5-4444-9FFF-7392B7401E5DQ34526677-7ACD784D-1417-48B8-9D31-7EF6314049E5Q34768583-8651BCE8-A495-4F7B-BC99-1F31B1F5A56EQ34973666-0FE24F35-1128-4423-AA18-4FD7F76B3CDAQ35166253-912D8AE8-5334-460A-819A-2CF3A87E7EEBQ35173183-0B879BA8-3CFF-4FAA-BE98-BCD40A327727Q35212008-8C62FA1B-2E72-482D-AB58-C42961FA09B8Q35680641-617BEDF3-346B-4EC4-B1D3-CC048CBD75B4Q36309109-EF1106BC-9C86-44D6-9A00-63E75B778377Q37361213-90B97B95-3A38-4348-B7B0-112006F636C8Q38669154-2D848F4E-5FEB-4F77-8CDD-6C88B24BBCE6Q39220841-14D34F57-61EF-452F-80F0-3411AC535034Q41093148-D1E00663-C8A5-4B55-85C4-D538C1CD16BBQ41826503-2DBF2D92-E53C-42A8-8B37-F7C178AC4EF7Q41991862-08425358-F9D6-493B-8559-DA0DDC78B057Q42244876-6F0471A5-8BCD-4A56-9547-72F29ED99708Q42424399-05F1C837-F29A-4119-8744-F2CE0AA7B503Q43194563-3FC2593E-9577-4F04-B005-593418B5ADC8Q43634188-32B6351C-14D4-4725-8376-1E22B6607481Q53855131-F5CF0A0B-EB75-4AEE-B03C-7253A7AE066BQ56499534-1D4A2953-1CC1-4909-BAC5-61BF3D34F9A9Q57727955-1A8D1CDD-4550-46A4-BA3E-DDE7009BC28B
P2860
IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
IB-367, a protegrin peptide wi ...... ssociated with oral mucositis.
@ast
IB-367, a protegrin peptide wi ...... ssociated with oral mucositis.
@en
type
label
IB-367, a protegrin peptide wi ...... ssociated with oral mucositis.
@ast
IB-367, a protegrin peptide wi ...... ssociated with oral mucositis.
@en
prefLabel
IB-367, a protegrin peptide wi ...... ssociated with oral mucositis.
@ast
IB-367, a protegrin peptide wi ...... ssociated with oral mucositis.
@en
P2093
P2860
P1476
IB-367, a protegrin peptide wi ...... ssociated with oral mucositis.
@en
P2093
P2860
P304
P356
10.1128/AAC.44.7.1803-1808.2000
P407
P577
2000-07-01T00:00:00Z